Human drug used to treat some animal prostate conditions recalled
National Report -- A human drug sometimes used by veterinarians to treat certain prostate conditions has been recalled due to a possible mislabeling error, according to the U.S. Food and Drug Administration (FDA).
National Report
-- A human drug sometimes used by veterinarians to treat certain prostate conditions has been recalled due to a possible mislabeling error, according to the U.S. Food and Drug Administration (FDA).
Finasteride, used to treat benign prostatic hyperplasia in humans, may been mislabeled as Citalopram, used to treat depression, by a third-party manufacturer, according to FDA. Bottles with the lot number FI0510058-A are affected by the recall.
Adverse reactions can be reported to FDA at (800) 332-1088.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
dvm360 announces winners of the Veterinary Heroes program
Published: September 6th 2024 | Updated: November 5th 2024This year’s event is supported by corporate sponsor Schwarzman Animal Medical Center and category sponsors Blue Buffalo Natural, MedVet, Banfield Pet Hospital, Thrive Pet Healthcare and PRN Pharmacal.
Read More
